Lv1
10 积分 2025-05-05 加入
KRASG12V/A146T mutations are associated with nCRT resistance via enhanced DNA double-strand break repair and support a deep learning prediction framework in LARC
10天前
已完结
Global research landscape and trends of immunotherapy in biliary tract cancers
10天前
已关闭
Prognostic model for predicting the survival benefit of adjuvant chemotherapy for elderly patients with stage II colon cancer: a population-based study
10天前
已完结
Effectiveness and conversion outcomes of immune checkpoint inhibitors combined with lenvatinib and GEMOX chemotherapy as first-line treatment for advanced gallbladder cancer: A multicenter study
11天前
已完结
肿瘤临床科学研究新范式
3个月前
已完结
Macro CD5L+ deteriorates CD8+T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma
8个月前
已完结
胆囊良性疾病诊治的研究进展
9个月前
已完结
Assessment of robotic versus laparoscopic gastrectomy for gastric cancer patients with intraoperative technical complexity a multicenter retrospective study
11个月前
已完结
Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCC
1年前
已完结
Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma
1年前
已完结
皖公网安备34019202002308
